Sutter Christian, Dallenbach-Hellweg Gisela, Schmidt Dietmar, Baehring Joachim, Bielau Simone, von Knebel Doeberitz Magnus, Gebert Johannes
Department of Pathology, University of Heidelberg, Germany.
Int J Gynecol Pathol. 2004 Jan;23(1):18-25. doi: 10.1097/01.pgp.0000101085.35393.4a.
Women predisposed to hereditary nonpolyposis colorectal cancer are at high risk of developing endometrial carcinoma at a young age. Hereditary nonpolyposis colorectal cancer-associated endometrial carcinomas are of the endometrioid type, usually arise from complex atypical hyperplasia, and often show microsatellite instability. To identify occult hereditary nonpolyposis colorectal cancer individuals among endometrial carcinoma patients, we examined complex atypical hyperplasias and endometrial carcinomas of 60 women < or =50 years of age (mean age: 35.7 years) using microsatellite instability, immunohistochemistry, and DNA sequence analysis. Three patient groups were recruited: group 1, patients with complex atypical hyperplasia exclusively (n = 27); group 2, patients with complex atypical hyperplasia and synchronous or metachronous endometrial carcinoma (n = 15); group 3, patients with endometrial carcinoma only (n = 18). Overall, 13 of 33 endometrial carcinomas (39%) displayed high-level microsatellite instability. None of the complex atypical hyperplasias in group 1 had high-level microsatellite instability or loss of hMLH1/hMSH2 protein expression. In group 2 patients, 33% of complex atypical hyperplasias and 53% of endometrial carcinomas had high-level microsatellite instability. Loss of hMSH2 protein expression was found in six endometrial carcinoma patients, five of them with verified hMSH2 germline mutations, including four patients with high-level microsatellite instability in complex atypical hyperplasia. Among group 3 patients, 28% of endometrial carcinomas displayed high-level microsatellite instability; three of those five endometrial carcinomas were from patients with multiple extrauterine hereditary nonpolyposis colorectal cancer-associated tumors. We conclude that young women (< or =50 years of age) with concurrent complex atypical hyperplasia and multiple hereditary nonpolyposis colorectal cancer-associated carcinomas are at risk of developing high-level microsatellite instability endometrial carcinoma. Combined microsatellite instability and immunohistochemistry analysis allows the identification of a high proportion of hereditary nonpolyposis colorectal cancer patients among young women with endometrial carcinoma and complex atypical hyperplasia. All complex atypical hyperplasias with high-level microsatellite instability progressed to endometrial carcinoma. Only one third of the complex atypical hyperplasias with microsatellite stability progressed to high-level microsatellite instability endometrial carcinoma, while seven complex atypical hyperplasias progressed to microsatellite stability endometrial carcinoma. Microsatellite analysis of complex atypical hyperplasia in young patients may therefore be a useful prognostic marker for predicting possible progression to high-level microsatellite instability endometrial carcinomas.
易患遗传性非息肉病性结直肠癌的女性在年轻时患子宫内膜癌的风险很高。遗传性非息肉病性结直肠癌相关的子宫内膜癌为子宫内膜样类型,通常起源于复杂性非典型增生,且常表现为微卫星不稳定性。为了在子宫内膜癌患者中识别隐匿的遗传性非息肉病性结直肠癌个体,我们使用微卫星不稳定性、免疫组织化学和DNA序列分析,对60名年龄≤50岁(平均年龄:35.7岁)女性的复杂性非典型增生和子宫内膜癌进行了检查。招募了三个患者组:第1组,仅患有复杂性非典型增生的患者(n = 27);第2组,患有复杂性非典型增生以及同步或异时性子宫内膜癌的患者(n = 15);第3组,仅患有子宫内膜癌的患者(n = 18)。总体而言,33例子宫内膜癌中有13例(39%)表现出高水平微卫星不稳定性。第1组的所有复杂性非典型增生均无高水平微卫星不稳定性或hMLH1/hMSH2蛋白表达缺失。在第2组患者中,33%的复杂性非典型增生和53%的子宫内膜癌有高水平微卫星不稳定性。在6例子宫内膜癌患者中发现了hMSH2蛋白表达缺失,其中5例经证实存在hMSH2种系突变,包括4例在复杂性非典型增生中有高水平微卫星不稳定性的患者。在第3组患者中,28%的子宫内膜癌表现出高水平微卫星不稳定性;这5例子宫内膜癌中有3例来自患有多种子宫外遗传性非息肉病性结直肠癌相关肿瘤的患者。我们得出结论,患有并发复杂性非典型增生和多种遗传性非息肉病性结直肠癌相关癌的年轻女性(年龄≤50岁)有发生高水平微卫星不稳定性子宫内膜癌的风险。联合微卫星不稳定性和免疫组织化学分析能够在患有子宫内膜癌和复杂性非典型增生的年轻女性中识别出高比例的遗传性非息肉病性结直肠癌患者。所有具有高水平微卫星不稳定性的复杂性非典型增生均进展为子宫内膜癌。仅有三分之一具有微卫星稳定性的复杂性非典型增生进展为高水平微卫星不稳定性子宫内膜癌,而7例复杂性非典型增生进展为微卫星稳定性子宫内膜癌。因此,对年轻患者的复杂性非典型增生进行微卫星分析可能是预测进展为高水平微卫星不稳定性子宫内膜癌可能性的有用预后标志物。